Schizoaffective Disorder News and Research

RSS

Weekend reading: Mental illness stigma, health insurance mazes and female libido

Linneah sat at a desk at the Center for Sexual Medicine at Sheppard Pratt in the suburbs of Baltimore and filled out a questionnaire. She read briskly, making swift checks beside her selected answers, and when she was finished, she handed the pages across the desk to Martina Miller, who gave her a round of pills.

24 May 2013

REFRESH study: RP5063 shows promise for schizophrenia and schizoaffective disorder

Reviva Pharmaceuticals, Inc., a privately held drug discovery and development company, today announces top-line results from REFRESH, a phase 2 clinical trial of RP5063 for the treatment of schizophrenia and schizoaffective disorder.

10 Apr 2013

Treating substance abuse alone helps patients with co-occurring psychosis

Patients with co-occurring substance use disorder and psychiatric disorders may benefit from standard substance use disorder treatment, with the effects potentially lasting for several years, the results of a US study indicate.

7 Mar 2013

Foreign-born adoptees most at risk for psychiatric disorders

Foreign-born adoptees have the highest rates of psychiatric disorders among migrants, show the results of a large, Danish population-based cohort study.

6 Mar 2013

Social cognition and negative symptoms scores reveal schizophrenia subgroups

Schizophrenia patients may be classified into three distinct subgroups, based on levels of social cognition and negative symptoms, that are associated with differences in community integration and quality of life, US study findings suggest.

5 Feb 2013

Family members with rare gene mutation at high risk of developing schizophrenia

Johns Hopkins researchers have identified a rare gene mutation in a single family with a high rate of schizophrenia, adding to evidence that abnormal genes play a role in the development of the disease.

22 Jan 2013

Reviva Pharmaceuticals completes enrollment in RP5063 phase 2 trial for schizophrenia

Reviva Pharmaceuticals, Inc., a privately held drug discovery and development company, today announces completion of patient enrollment in the phase 2 clinical trial of RP5063 for the treatment of schizophrenia and schizoaffective disorder.

16 Jan 2013

Metabolic syndrome linked to poorer cognition in schizophrenia

Schizophrenia patients with the metabolic syndrome have poorer cognitive functioning than those without, results from a US study show.

9 Nov 2012

People in creative professions are treated more often for mental illness

People in creative professions are treated more often for mental illness than the general population, there being a particularly salient connection between writing and schizophrenia. This according to researchers at Karolinska Institutet in Sweden, whose large-scale registry study is the most comprehensive ever in its field.

17 Oct 2012

Maternal obstetric problems linked to schizophrenia risk

Certain maternal pregnancy complications are associated with an increased risk for schizophrenia spectrum psychoses among individuals at high genetic risk for the condition, Finnish research shows.

25 Sep 2012

Kynurenic acid levels reduced in suicide attempters with schizophrenia

Cerebrospinal fluid concentrations of kynurenic acid are significantly lower in schizophrenia-spectrum patients with a history of suicide attempts than in those without, researchers report.

13 Sep 2012

Night eating syndrome increased in schizophrenia patients

The prevalence of night eating syndrome is significantly increased among patients with schizophrenia or schizoaffective disorder who are obese, results from a US study suggest.

6 Sep 2012

DUP may differentiate schizoaffective disorder from BD

Among individuals with a first episode of psychotic mania (FEPM), a longer duration of untreated psychosis may differentiate patients with schizoaffective disorder from those with bipolar I disorder, study results suggest.

29 Aug 2012

Interhemispheric coordination reduced in schizophrenia

Results from a US study show that patients with schizophrenia have significantly decreased interhemispheric coordination compared with mentally healthy individuals.

21 Aug 2012

PTSD prevalent in serious mental illness patients

Post-traumatic stress disorder is common among patients with serious mental illnesses, and is associated with an increased risk for suicide attempts, Spanish researchers report.

2 Aug 2012

SCIT may benefit affective disorder patients

Social cognition and interaction training may improve certain aspects of social cognition and functioning in patients with affective disorders, results from a preliminary study suggest.

27 Jul 2012

PTSD prevalent in serious mental illness patients

Post-traumatic stress disorder is common among patients with serious mental illnesses, and is associated with an increased risk for suicide attempts, Spanish researchers report.

26 Jul 2012

Cognitive function linked to suicidality in schizophrenia

Patients with schizophrenia who have contemplated suicide or made one suicide attempt have better cognitive functioning than those who have not, research shows.

19 Jul 2012

Obsessive compulsive symptoms impair life quality in psychosis patients

The presence of obsessive compulsive symptoms is associated with reduced subjective wellbeing and quality of life in patients with a first episode of psychosis, Dutch researchers report.

17 Jul 2012